Elite Pharmaceuticals, Inc. Public Float
Elite Pharmaceuticals, Inc. (ELTP) had Public Float of $534.00 million as of 2025-09-30, per its 10-K filed 2026-06-29.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-06-29
- 2025-09-30: Entity Public Float $534.00M.
- 2024-09-30: Entity Public Float $323.30M.
- 2023-09-30: Entity Public Float $95.11M.
- 2022-09-30: Entity Public Float $40.56M.
| Period end | Entity Public Float |
|---|---|
| 2025-09-30 | $534.00M 10-K · filed 2026-06-29 |
| 2024-09-30 | $323.30M 10-K · filed 2025-06-30 |
| 2023-09-30 | $95.11M 10-K · filed 2024-07-01 |
| 2022-09-30 | $40.56M 10-K/A · filed 2023-07-31 |
| 2021-09-30 | $40.46M 10-K · filed 2022-06-29 |
| 2020-09-30 | $56.14M 10-K · filed 2021-06-14 |
| 2019-09-30 | $65.06M 10-K · filed 2020-06-29 |
| 2018-09-30 | $73.52M 10-K · filed 2019-06-21 |
| 2017-09-30 | $79.38M 10-K · filed 2018-06-14 |
| 2016-09-30 | $157.27M 10-K · filed 2017-06-14 |
| 2015-09-30 | $156.80M 10-K · filed 2016-06-15 |
| 2014-09-30 | $153.85M 10-K · filed 2015-06-15 |
| 2013-09-30 | $61.31M 10-K · filed 2014-06-30 |
| 2012-09-30 | $41.96M 10-K · filed 2013-06-21 |
| 2010-09-30 | $25.73M 10-K · filed 2012-06-29 |